Xeden 15 mg for cats, 120 tablets | Treatment of upper respiratory tract infections

XEDEN Tablets Enrofloxacin divisible tablets for dogs and cats

Pharmaceutical form

Oral tablet (Comp.o.)

Composition by tablet:

– Xeden 15 mg: Enrofloxacin 15 mg.

– Xeden 50 mg: Enrofloxacin 50 mg.

– Xeden 150 mg: Enrofloxacin 150 mg.

Pharmacological properties

Enrofloxacin is a synthetic antibiotic of the fluoroquinolone family, with concentration-dependent bactericidal activity. It presents good activity against most Gram (-) bacteria, especially Enterobacteriaceae. Escherichia coli, Klebsiella spp., Proteus spp. and Enterobacter spp., are generally susceptible. The susceptibility of Pseudomonas aeruginosa is variable. Staphylococcus aureus and Staphylococcus intermedius are usually susceptible.

Interactions and incompatibilities

Concomitant use with theophylline requires adequate monitoring as theophylline serum levels may be increased.

Concomitant use with substances containing magnesium or aluminum (such as antacids or sucralfate) may reduce the absorption of enrofloxacin. For this reason, these substances must be administered two hours after the administration of this medicine.

Do not use with tetracyclines, phenicols or macrolides due to possible antagonistic effects.

Indications

Cats: Treatment of upper respiratory tract infections.

Dogs: Treatment of lower urinary tract infections (associated or not with prostatitis) and upper urinary tract infections caused by Escherichia coli or Proteus mirabilis; treatment of superficial and deep pyoderma.

Contraindications

Do not use in case of resistance to quinolones.

Do not administer to animals with nervous disorders, as enrofloxacin may cause CNS stimulation.

Do not use in young growing kittens, as there is a possibility of cartilage lesions (cats less than 3 months old or weighing less than 1 kg).

Do not use in puppies or growing dogs (dogs less than 12 months of age in small breeds or less than 18 months of age in large breeds), as it may cause alterations in the epiphyseal cartilage in growing puppies.

Adverse reactions

During treatment cases of vomiting or diarrhea may appear. These signs subside spontaneously and treatment interruption is generally not necessary.

Possible articular cartilage alterations in growing puppies.

Route of administration

Orally.

The tablets are flavored and are well accepted by animals. They can be administered directly into the animal's mouth or by adding them to food.

Posology

Cats: 5 mg of enrofloxacin/kg of weight, once a day for 5 to 10 consecutive days.

Dogs: 5 mg of enrofloxacin/kg/day, once a day for: 10 days in lower urinary tract infections; 15 days in upper and lower urinary tract infections associated with prostatitis; up to 21 days in superficial pyodermas depending on the clinical response; up to 49 days in deep pyodermas depending on the clinical response.

Special precautions

Pyoderma is mostly secondary to an underlying process. It is necessary to determine the underlying cause and treat the animal appropriately.

Use the product with care in cats in cases of severe renal or hepatic insufficiency.

Wait time

Not applicable.

conservation mode

It does not require special storage temperature conditions.

Comments

With veterinary prescription.

Data sheet